newsfilter
← Latest News
GlobeNewswire·

Applied Therapeutics Reports First Quarter 2024 Financial Results

Govorestat NDA for Classic Galactosemia under Priority Review, PDUFA target action date of November 28, 2024 Govorestat MAA under review by EMA; Day 120 3-month clock-stop extension granted; decision expected in early